SecBot SecBot
144 ·Filed Jul 14, 2026

CELC

Celcuity Inc.
BEARISH
Impact 6/10
Horizonweeks Processed4mo ago SEC0001104659-26-083659
Actionable Insight ▼ Bearish

Monitor for subsequent Form 4 filings confirming actual sales. The large proposed sale by a major institutional affiliate suggests potential near-term selling pressure. Traders should watch for accelerated execution through Goldman Sachs and consider the overhang on CELC's stock price.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$91.51
T+0 close · Jul 14, 2026 · via day close
Latest settled
−25.83%
T+60 · $67.87
Vs SPY
−28.37%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 15 $91.51entry
  2. T+1 · 4mo ago −3.52%α −2.98% · $88.29
  3. T+5 · 4mo ago −1.50%α −0.52% · $90.14
  4. T+20 · 3mo ago +0.62%α −1.72% · $92.08
  5. T+60 · 6w ago −25.83%α −28.37% · $67.87
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Baker Brothers affiliates (667, L.P. and Baker Brothers Life Sciences L.P.) filed Form 144 notices to sell a combined 3,100,000 shares of Celcuity Inc. common stock, valued at approximately $317.75 million. This represents about 6.35% of outstanding shares and signals a significant reduction in exposure by a major healthcare-focused institutional investor.

Key Facts

  • 667, L.P. intends to sell 261,368 shares worth ~$26.79 million.
  • Baker Brothers Life Sciences L.P. intends to sell 2,838,632 shares worth ~$290.96 million.
  • Combined proposed sale: 3,100,000 shares, approximately $317.75 million (6.35% of outstanding shares).
  • Shares were purchased between 12/13/2024 and 5/16/2025 in open market transactions.
  • Filing signed by Scott L. Lessing, President of Baker Bros. Advisors LP, the investment adviser to both entities.

Financial Impact

Approximately $317.75 million of stock to be sold, representing ~6.35% of outstanding shares (based on 48,766,288 shares outstanding noted in the filing).

dilutionsupplyOverhang

Risk Factors

  • Large block sale could depress share price if executed rapidly.
  • Signals reduced conviction from a knowledgeable long-term investor (Baker Brothers).
  • Remaining 93.65% of shares still held by other insiders/institutions, but this sale is material.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 12 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (CELC), Batch item 10001104659-26-083659
Document: 0001104659-26-083659-index.html0001104659-26-083657
Document: 0001104659-26-083659.txt0001104659-26-083659
144 Filing (CELC), Batch item 40001104659-26-083657
Document: 0001104659-26-083657-index.html0001104659-26-083659
Document: 0001104659-26-083657.txt0001104659-26-083659
144 Filing (CELC), Batch item 70001104659-26-083659
Document: 0001104659-26-083659-index.html0001104659-26-083659
Document: 0001104659-26-083659.txt0001104659-26-083659
144 Filing (CELC), Batch item 100001104659-26-083657
Document: 0001104659-26-083657-index.html0001104659-26-083659
Document: 0001104659-26-083657.txt0001104659-26-083659

Track record

26 reports on CELC

Performance horizon

6 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +26.84% at T+20 after the Jun 11, 2026 report. 8 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $62.58 Now $60.57 −3.21% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $64.37 Now $60.57 −5.90% settles Nov 23
  3. Nov 9, 20267d ago Press Release Bullish 5/10 Entry $70.37 to $60.57 Now $60.57 −13.93% ▼ −13.93% −12.23% vs SPY
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $66.79 to $64.37 Now $60.57 −9.31% ▼ −3.62% −6.22% vs SPY
  6. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $69.72 to $67.05 Now $60.57 −13.12% ▼ −3.83% −3.24% vs SPY
  7. Oct 24, 202623d ago Press Release Bullish 6/10 Entry $65.80 to $69.13 Now $60.57 −7.95% ▲ +5.06% +6.32% vs SPY
  8. Oct 5, 20266w ago 3 Neutral 2/10 Entry $71.25 to $63.19 Now $60.57 −14.99% ▼ −11.31% −11.17% vs SPY
  9. Oct 2, 20266w ago 8-K Neutral 2/10 Entry $72.10 to $67.94 Now $60.57 −15.99% ▼ −5.77% −6.93% vs SPY
  10. Sep 30, 20266w ago 8-K Bullish 6/10 Entry $79.52 to $65.78 Now $60.57 −23.83% ▼ −17.28% −19.19% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 8h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 14, 2026